This 1-hour accredited program will help GPs understand the significant burden of shingles in Australia, including the risks of post-herpetic neuralgia (PHN) and stroke, and the rationale for vaccination. The program will support clinicians in proactively identifying individuals aged ≥50 years who may benefit from shingles vaccination, such as those with diabetes, and assist them in managing shingles vaccination in the context of immunosuppressive therapies.
Featuring three cases studies and expert video questions, this program highlights the importance of identifying patients who will benefit from shingles vaccination.
This educational activity was developed by MDBriefCase at the request, and with funding from Seqirus.